Could This Drug Help Cancer Patients Live Longer?

Claims are swirling after results from a Phase III clinical trial.

Results from a Phase III clinical trial have Bayer AG saying their drug can extend the lives of liver cancer patients, according to Reuters.

The drug the company is speaking of is called Regorafenib.

And according to Reuters, the company's next move is to file for regulatory approval of the oncology compound.

List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
List: Digitalization Companies From PACK EXPO
Sustainable Healthcare Packaging Solutions That Work
Industry leaders share proven strategies for reducing packaging emissions by up to 70% while meeting safety and regulatory requirements.
Read More
Sustainable Healthcare Packaging Solutions That Work